Citadel Advisors
CALC icon

Citadel Advisors’s CalciMedica CALC Stock Holding History

Citadel Advisors’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74K Buy
14,360
+10,720
+295% +$38K ﹤0.01% 12890
2026
Q1 		$9.83K Buy
+3,640
New +$36.9K ﹤0.01% 12763
2023
Q1 		– Sell
-507
Closed -$17.8K – 14759
2022
Q4 		$17.8K Sell
507
-230
-31% -$12.9K ﹤0.01% 13231
2022
Q3 		$49K Sell
737
-122
-14% -$8.64K ﹤0.01% 11643
2022
Q2 		$66K Buy
859
+472
+122% +$32.2K ﹤0.01% 11750
2022
Q1 		$33K Sell
387
-550
-59% -$52.4K ﹤0.01% 13049
2021
Q4 		$120K Sell
937
-386
-29% -$75K ﹤0.01% 12525
2021
Q3 		$307K Sell
1,323
-664
-33% -$187K ﹤0.01% 11031
2021
Q2 		$755K Buy
+1,987
New +$652K ﹤0.01% 9086

Other funds holding CALC

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
LGM
L1 Global Manager Melbourne $142M AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors's CALC Position: Q2 2022 in Review

Citadel Advisors sold out of CalciMedica (CALC) in Q2 2022, closing a stake of 737 shares — an estimated $50.3K sold.

Citadel Advisors first reported a position in CALC in Q3 2020 and held it in 4 quarters. The position peaked at $4.96M in Q3 2020. 25 funds tracked by Wall St. Rank hold CALC as of Q2 2022.

  • Citadel Advisors reported no remaining CalciMedica position as of Q2 2022 after selling out during the quarter.
  • Citadel Advisors sold 737 CalciMedica shares in Q2 2022, an estimated $50.3K.
  • Citadel Advisors first reported a position in CalciMedica in Q3 2020 and held it in 4 quarters.
  • Citadel Advisors's CalciMedica position peaked at $4.96M in Q3 2020.
  • 25 funds tracked by Wall St. Rank held CalciMedica as of Q2 2022.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.